Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 19,64119,660 of 20,252 grants

Completed TRAINING, INDIVIDUAL
Development of a tumor-activated IL12 prodrug to treat solid tumors
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2021 – 2025

Project Summary/Abstract: Despite recent advances in cancer immunotherapy, solid tumors remain largely refractory to treatment due to disruption of immune homeostasis by the tumor...

$365.5K
USD
Completed NON-SBIR/STTR RPGS
Discovering the role of YES1 in triple negative breast cancer
NATIONAL CANCER INSTITUTE Cleveland Clinic Lerner Com-Cwru United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT SRC Family Kinases (SFKs) are a group of 9 non-receptor tyrosine kinases that mediate the effects of many extracellular and intracellular signaling pathway...

$4.61M
USD
Completed TRAINING, INDIVIDUAL
Investigating macrophage-to-tumor mitochondrial transfer
NATIONAL CANCER INSTITUTE University of Utah United States 2021 – 2024

Project Summary Tumor metastasis is the leading cause of cancer related mortalities, yet preventing this malignant phenotype continues to elude scientific investigators.In efforts...

$370.3K
USD
Completed TRAINING, INDIVIDUAL
Metabolically improving the generation, function, and persistence of therapeutic T cells for the treatment of cancer
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2021 – 2023

Project Summary Immunotherapy has shifted the paradigm in the understanding and treatment of cancer.Within this arsenal of new treatment strategies, adoptive cell therapy (ACT) has...

$460.4K
USD
Completed NON-SBIR/STTR RPGS
Targeting AR and AR-Variants in Castration-Resistant Prostate Cancer
NATIONAL CANCER INSTITUTE Texas A&M University Health Science Ctr United States 2021 – 2026

Project Summary/Abstract Current AR inhibitors (enzalutamide and abiraterone) inhibit either the conversion of androgen to dihydrotestosterone (DHT), block androgen binding to andr...

$3.95M
USD
Completed NON-SBIR/STTR RPGS
Role of cDC2 subsets in host protection and CD4T cell responses in melanoma
NATIONAL CANCER INSTITUTE Rbhs-New Jersey Medical School United States 2021 – 2023

Project Summary Despite recent successes, many melanoma patients still fail to respond to immunotherapy and there is a pressing need for identifying novel therapeutic targets.The p...

$2.14M
USD
Completed NON-SBIR/STTR RPGS
Mitochondrial lateral transfer during metastasis
NATIONAL CANCER INSTITUTE University of Utah United States 2021 – 2026

Project Summary Macrophages play paradoxical roles in cancer: They can be tumoricidal, but in many cancers, macrophages promote metastasis. There has been growing evidence that mac...

$3.49M
USD
Completed NON-SBIR/STTR RPGS
Targeting B7-H3 in ovarian cancer
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2026

ABSTRACT Remarkable clinical responses have been reported in B-cell malignancies by adoptive transfer of T cells redirected with a chimeric antigen receptor (CAR) specific for the...

$6.2M
USD
Completed NON-SBIR/STTR RPGS
Overcoming ibrutinib resistance in mantle cell lymphoma
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2021 – 2026

Project Abstract Ibrutinib, a covalent inhibitor of Bruton tyrosine kinase (BTK) and similar inhibitors of B-cell receptor (BCR)- associated kinases are shifting the therapeutic la...

$4.51M
USD
Completed NON-SBIR/STTR RPGS
The role of PARP10 in alleviating replication stress and promoting cellular proliferation and tumorigenesis
NATIONAL CANCER INSTITUTE Pennsylvania State University Hershey Me... United States 2021 – 2026

Project Summary Identification of molecular pathways that are preferentially employed and relied upon by cancer cells compared to normal cells is key to designing novel personalize...

$3.68M
USD
Completed NON-SBIR/STTR RPGS
Targeting tumor architecture as a novel therapeutic strategy for pancreatic cancer
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2021 – 2026

Pancreatic ductal adenocarcinoma (PDAC) is one of the most chemorefractory cancers among solid tumors. Even with the most effective chemotherapy (i.e., FOLFIRINOX), only 30% of PDA...

$4.6M
USD
Completed TRAINING, INDIVIDUAL
T cell mechanisms of immunotherapy response in pancreatic ductal adenocarcinoma
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2022

Project Summary Immune checkpoint inhibitors (ICIs) provide durable clinical responses in about 20% of cancer patients, but have been largely ineffective for non-immunogenic cancer...

$278.9K
USD
Completed OTHER RESEARCH-RELATED
Cancer misinformation on social media and its correction
NATIONAL CANCER INSTITUTE Northeastern University United States 2021 – 2024

Project Summary The overarching goal of this study is to measure the prevalence of cancer misinformation on social media and understand the mechanisms that underlies its spread. Be...

$1.54M
USD
Completed TRAINING, INDIVIDUAL
Tracing Intratumoral Cellular Heterogeneity using genetic barcoding in small cell lung cancer
NATIONAL CANCER INSTITUTE University of South Dakota United States 2021 – 2022

PROJECT SUMMARY Tumors are often highly heterogeneous, with a number of functionally different cells existing within a single tumor, giving some cells the ability to initiate new t...

$287.2K
USD
Completed TRAINING, INDIVIDUAL
The role of cellular senescence in chemotherapy-related cognitive impairment
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2021 – 2022

PROJECT SUMMARY The etiology of chemotherapy-related cognitive impairment (CRCI) is understudied despite the growing clinical awareness of its contribution to patient morbidity. Di...

$586.7K
USD
Completed TRAINING, INDIVIDUAL
RNA Polymerase I Associated Factors: Novel Targets in Cancer Therapy
NATIONAL CANCER INSTITUTE University of Oklahoma Hlth Sciences Ctr United States 2021 – 2023

PROJECT SUMMARY/ABSTRACT The regulation of ribosome biogenesis (RB) plays a central role in maintaining cellular homeostasis and supporting cell growth. The rate-limiting step in t...

$342.6K
USD
Completed TRAINING, INDIVIDUAL
Investigating macrophage-to-tumor mitochondrial transfer
NATIONAL CANCER INSTITUTE University of Utah United States 2021 – 2024

Project Summary Tumor metastasis is the leading cause of cancer related mortalities, yet preventing this malignant phenotype continues to elude scientific investigators. In efforts...

$377.5K
USD
Completed NON-SBIR/STTR RPGS
Role of Erbb3 kinase activity in colorectal tumorigenesis.
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2021 – 2026

The overarching goals of this proposal are to determine if Erbb3 kinase plays a critical role in colorectal tumorigenesis and to test if colorectal cancer with oncogenic Erbb3 muta...

$4.26M
USD
Completed OTHER RESEARCH-RELATED
The ontogeny and function of CD8 T cells in lung cancer
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2021 – 2022

PROJECT SUMMARY/ABSTRACT Targeting the immune system to destroy cancer cells using immunotherapy has rapidly emerged as a promising avenue for treating cancer, and has resulted in...

$2.18M
USD
Completed TRAINING, INDIVIDUAL
Effects of GPCR trafficking on the spatiotemporal control of signaling
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2024

Project Summary/Abstract G protein coupled receptors (GPCRs) constitute a family of signaling receptors that regulate essentially every physiological process. Recent studies have b...

$702.8K
USD